These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24129254)

  • 1. Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.
    Lewis LA; Vu DM; Vasudhev S; Shaughnessy J; Granoff DM; Ram S
    mBio; 2013 Oct; 4(5):e00339-13. PubMed ID: 24129254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model.
    Lewis LA; Vu DM; Granoff DM; Ram S
    Infect Immun; 2014 Jun; 82(6):2574-84. PubMed ID: 24686052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.
    Giuntini S; Pajon R; Ram S; Granoff DM
    Infect Immun; 2015 Apr; 83(4):1536-45. PubMed ID: 25644002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci.
    Lewis LA; Carter M; Ram S
    J Immunol; 2012 May; 188(10):5063-72. PubMed ID: 22504643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.
    Shaughnessy J; Lewis LA; Jarva H; Ram S
    Infect Immun; 2009 May; 77(5):2094-103. PubMed ID: 19273554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
    Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.
    Lewis LA; Ngampasutadol J; Wallace R; Reid JE; Vogel U; Ram S
    PLoS Pathog; 2010 Jul; 6(7):e1001027. PubMed ID: 20686663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.
    Rossi R; Konar M; Beernink PT
    Infect Immun; 2016 Jun; 84(6):1735-1742. PubMed ID: 27021245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.
    Tzeng YL; Giuntini S; Berman Z; Sannigrahi S; Granoff DM; Stephens DS
    Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32958529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides.
    Agarwal S; Vasudhev S; DeOliveira RB; Ram S
    J Immunol; 2014 Aug; 193(4):1855-63. PubMed ID: 25015832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis.
    Piet JR; Brouwer MC; Exley R; van der Veen S; van de Beek D; van der Ende A
    PLoS One; 2012; 7(10):e47973. PubMed ID: 23110143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.
    Giuntini S; Vu DM; Granoff DM
    Vaccine; 2013 Aug; 31(38):4192-9. PubMed ID: 23791680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
    Veggi D; Bianchi F; Santini L; Lo Surdo P; Chesterman CC; Pansegrau W; Bechi N; Huang Y; Masignani V; Pizza M; Rappuoli R; Bottomley MJ; Cozzi R; Maione D
    PLoS Pathog; 2020 Oct; 16(10):e1008882. PubMed ID: 33007046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
    Marini A; Rossi O; Aruta MG; Micoli F; Rondini S; Guadagnuolo S; Delany I; Henderson IR; Cunningham AF; Saul A; MacLennan CA; Koeberling O
    PLoS One; 2017; 12(7):e0181508. PubMed ID: 28742866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.
    Beernink PT; Shaughnessy J; Pajon R; Braga EM; Ram S; Granoff DM
    PLoS Pathog; 2012; 8(5):e1002688. PubMed ID: 22589720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.
    Pajon R; Fergus AM; Koeberling O; Caugant DA; Granoff DM
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1302. PubMed ID: 21909444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding.
    Costa I; Pajon R; Granoff DM
    mBio; 2014 Aug; 5(5):e01625-14. PubMed ID: 25161192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.
    Johnson S; Tan L; van der Veen S; Caesar J; Goicoechea De Jorge E; Harding RJ; Bai X; Exley RM; Ward PN; Ruivo N; Trivedi K; Cumber E; Jones R; Newham L; Staunton D; Ufret-Vincenty R; Borrow R; Pickering MC; Lea SM; Tang CM
    PLoS Pathog; 2012; 8(10):e1002981. PubMed ID: 23133374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.
    Beernink PT; Shaughnessy J; Braga EM; Liu Q; Rice PA; Ram S; Granoff DM
    J Immunol; 2011 Mar; 186(6):3606-14. PubMed ID: 21325619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.
    Ram S; Lewis LA; Agarwal S
    J Biol Chem; 2011 Mar; 286(10):8297-8307. PubMed ID: 21245150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.